Healthcare provider profile · identity verified

Jared P Lambert, MD

Family Practice · ARLINGTON, WA · NPI 1932693512

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	342	103
Lisinopril	Lisinopril	260	72
Gabapentin	Gabapentin	188	39
Amlodipine Besylate	Amlodipine Besylate	187	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	179	39
Oxycodone Hcl	Oxycodone Hcl	150	24
Trazodone Hcl	Trazodone Hcl	148	35
Albuterol Sulfate Hfa	Albuterol Sulfate	146	48
Levothyroxine Sodium	Levothyroxine Sodium	114	35
Metoprolol Succinate	Metoprolol Succinate	106	29
Hydrochlorothiazide	Hydrochlorothiazide	98	29
Metformin Hcl	Metformin Hcl	96	30
Tamsulosin Hcl	Tamsulosin Hcl	93	22
Losartan Potassium	Losartan Potassium	89	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	85	16
Sertraline Hcl	Sertraline Hcl	80	22
Pantoprazole Sodium	Pantoprazole Sodium	75	26
Furosemide	Furosemide	71	15
Omeprazole	Omeprazole	71	23
Simvastatin	Simvastatin	68	19
Meloxicam	Meloxicam	58	22
Ventolin Hfa	Albuterol Sulfate	56	suppressed
Allopurinol	Allopurinol	55	12
Eliquis	Apixaban	55	13
Alprazolam	Alprazolam	52	suppressed
Atenolol	Atenolol	52	16
Pregabalin	Pregabalin	52	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Metformin Hcl Er	Metformin Hcl	50	13
Potassium Chloride	Potassium Chloride	50	13
Rosuvastatin Calcium	Rosuvastatin Calcium	49	16
Warfarin Sodium	Warfarin Sodium	48	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	12
Carvedilol	Carvedilol	45	12
Ozempic	Semaglutide	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	11
Bupropion Xl	Bupropion Hcl	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Ramelteon	Ramelteon	40	suppressed
Rybelsus	Semaglutide	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Baclofen	Baclofen	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Finasteride	Finasteride	34	11
Methocarbamol	Methocarbamol	34	13
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Prednisone	Prednisone	30	11
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	11
Lubiprostone	Lubiprostone	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Famotidine	Famotidine	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Lactulose	Lactulose	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Azithromycin	Azithromycin	16	13
Donepezil Hcl	Donepezil Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Estradiol (Once Weekly)	Estradiol	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Emgality Pen	Galcanezumab-Gnlm	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Savella	Milnacipran Hcl	14	suppressed
Testosterone	Testosterone	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Digoxin	Digoxin	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Estradiol	Estradiol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error